Sabag Mark sold TEVA
May 1, 2026 · Form 4 insider transaction
Sabag Mark sold 144,180 shares of Teva Pharmaceutical Industries Limited at $34.99 per share, a transaction worth $5.05M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.935 to $35.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.